Medicxi Ventures Management Ltd, a registered investment adviser, initiated a new position in Centessa Pharmaceuticals plc (NASDAQ:CNTA) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 19,963,157 shares of the Healthcare company, valued at approximately $499.3M as of the filing date.
Centessa Pharmaceuticals plc's stock currently trades at $26.05 with a market capitalization of $3.7B.